Claris Ventures SGR
Claris Ventures SGR is a Turin-based, Bank of Italy-authorised venture capital manager founded in 2019 that invests in early-stage biopharma companies from the Italian and European research ecosystem, addressing unmet clinical needs across rare diseases, oncology, immunology, metabolic and CNS disorders. Its flagship fund, Claris Biotech I, reached an EUR 85 million final close in July 2021, and the firm is now raising Claris Biotech II.
Key facts
Recent exits
No exits recorded yet.
Coverage notes
1 fund tracked, 11 portfolio companies (11 active · 0 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Claris Ventures SGR has raised, with its portfolio companies. Hand-checked from public filings.
Claris Biotech ILife Sciences VCHarvesting2020 · 6yr€85M11 active
Unrealized
11 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Biotech | 2023 | ||
| Biotech | 2025 | ||
| Biotech | 2022 | ||
| Biotech | 2022 | ||
| Biotech | 2022 | ||
| Biotech | 2025 | ||
| Biotech | 2021 | ||
| Biotech | 2024 | ||
| Biotech | 2023 | ||
| Biotech | 2021 | ||
| Biotech | 2022 |
Saved GPs appear in your watchlist, one click from your workspace.
Similar firms
Other private equity firms tracked on GP Intel.
Get the full picture on Claris Ventures SGR.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in